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DFI-seq identification of environment-
specific gene expression in uropathogenic
Escherichia coli
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and Jakob Møller-Jensen1*
Abstract
Background: During infection of the urinary tract, uropathogenic Escherichia coli (UPEC) are exposed to different
environments, such as human urine and the intracellular environments of bladder epithelial cells. Each environment
elicits a distinct bacterial environment-specific transcriptional response. We combined differential fluorescence
induction (DFI) with next-generation sequencing, collectively termed DFI-seq, to identify differentially expressed
genes in UPEC strain UTI89 during growth in human urine and bladder cells.
Results: DFI-seq eliminates the need for iterative cell sorting of the bacterial library and yields a genome-wide view
of gene expression. By analysing the gene expression of UPEC in human urine we found that genes involved in
amino acid biosynthesis were upregulated. Deletion mutants lacking genes involved in arginine biosynthesis were
outcompeted by the wild type during growth in human urine and inhibited in their ability to invade or proliferate
in the J82 bladder epithelial cell line. Furthermore, DFI-seq was used to identify genes involved in invasion of J82
bladder epithelial cells. 56 genes were identified to be differentially expressed of which almost 60% encoded
hypothetical proteins. One such gene UTI89_C5139, displayed increased adhesion and invasion of J82 cells when
deleted from UPEC strain UTI89.
Conclusions: We demonstrate the usefulness of DFI-seq for identification of genes required for optimal growth of
UPEC in human urine, as well as potential virulence genes upregulated during infection of bladder cell culture. DFI-
seq holds potential for the study of bacterial gene expression in live-animal infection systems. By linking fitness
genes, such as those genes involved in amino acid biosynthesis, to virulence, this study contributes to our
understanding of UPEC pathophysiology.
Keywords: DFI, NGS, UPEC, Amino acid biosynthesis, Virulence, UTI
Background
Urinary tract infections (UTIs) are one of the most com-
mon infectious diseases and approximately 40–50% of
women will experience a UTI in the course of their life-
time. Symptoms can range from mild irritative voiding,
to bacteraemia, sepsis, and even death [1]. The eco-
nomic burden is high and in 2010 it was estimated that
the annual direct and indirect cost of UTIs in the United
States was $2.3 billion. A wide range of bacterial species
including Klebsiella spp., Pseudomonas aeruginosa and
Streptococcus agalactiae are capable of causing UTIs.
The majority of infections are however caused by uro-
pathogenic E. coli (UPEC), which is responsible for 75%
of all community-acquired UTIs [2].
UPEC bacteria encounter histologically distinct envi-
ronments during their ascent through the urinary tract
of humans. Colonization of the periurethral area is
followed by bacterial entry into the bladder via the ur-
ethra. UPEC grow and persist in the bladder despite the
constant urine flow they experience. During acute infec-
tion of the bladder, UPEC infect bladder epithelial cells
(BECs) to initiate biofilm-like intracellular bacterial
* Correspondence: jakobm@bmb.sdu.dk
1Department of Biochemistry and Molecular Biology, University of Southern
Denmark, Campusvej 55, 5230 Odense M, Denmark
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Madelung et al. BMC Microbiology  (2017) 17:99 
DOI 10.1186/s12866-017-1008-4
community (IBC) formation [3]. The acute infection
ends with superficial BECs being exfoliated due to in-
flammation brought on by the invading bacteria [4]. At
the same time, IBCs mature and the intracellular bacter-
ial population display phenotypic variation; some cells
become motile and rod-shaped while others turn into
filaments more than 50 micrometer in length. At this
stage the bacteria burst out into the lumen of the blad-
der [5]. The inflammation brought on by UPEC leads to
recruitment of polymorphonuclear neutrophils (PMNs)
into the bladder, which eliminates the majority of the re-
leased rod shaped UPEC. Filamentous bacteria resist
clearance by the PMNs however, and are capable of
reverting back to rod shape to initiate a second round of
infection and IBC formation [6–8]. Bladder cell exfoli-
ation renders underlying layers of undifferentiated tissue
accessible to bacterial invasion. Inside the deeper tissue
layers, UPEC can form quiescent intracellular reservoirs
(QIRs), consisting of a single or few non-dividing bac-
teria. These QIRs may constitute a reservoir for recur-
rent UTIs [5, 9]. From the bladder, UPEC can further
ascend the ureters to the kidneys where they trigger in-
flammation. Finally, in severe cases, UPEC may traverse
into the bloodstream causing life-threatening sepsis [10].
Several virulence- or fitness-associated factors have
been identified to be involved in UPEC infection of the
urinary tract. Among these factors are adhesive fimbriae:
type-1 fimbriae which bind to the urothelium of the
bladder during acute infection [11], F9/Yde/Fml pili
which are involved in specific binding to inflamed blad-
der tissue [12], and P fimbriae that are important during
kidney infections [13]. Additional factors include the K1
capsule, which has a role in facilitating intracellular
UPEC proliferation and IBC formation [14], the surface
adhesin antigen 43, an autotransporter protein that pro-
motes autoaggregation and is expressed by the bacteria
embedded in the polysaccharide matrix of IBCs [3], iron
acquisition genes necessary for bacterial growth in the
iron limited environment of the host [15], and the toxins
α-Hemolysin [16, 17], cytotoxic necrotizing factor type 1
[17] and secreted autotransporter toxin [18], all affecting
the host urothelium during infection.
Recently, a redefinition of the concept of bacterial
virulence was proposed [19]. It has been shown that
UPEC fitness in the urinary tract depends on the tricarb-
oxylic acid cycle and gluconeogenesis [20]. Moreover,
peptide transporters have been shown to be induced in
urine and to be required for fitness during infection
[20]. Hence, virulence is determined by the sum of re-
quired metabolic pathways, the traditional virulence de-
terminants, and upregulated transport systems and other
indispensable functions [19]. In this study, we focus on
environment-specific gene expression to further our un-
derstanding of UPEC pathophysiology. The experiments
are centred on identification of genes involved in
environment-specific adaptation, growth, and persistence
during urine exposure in the bladder, and invasion and
intracellular proliferation in the superficial cells of the
bladder.
We combined the differential fluorescence induction
(DFI) technique [21] with next-generation sequencing
(NGS) to identify UPEC genes that are differentially
expressed in response to human urine and growth inside
the BEC line J82.
In DFI, a promoter trap library is created by inserting
chromosomal DNA fragments from the bacteria of inter-
est into a plasmid containing a promoterless gfp gene, en-
coding green fluorescent protein (GFP). The plasmids are
then transformed into the bacteria of interest. The result-
ing promoter trap library is subjected to the conditions
under investigation and to a reference condition. By per-
forming consecutive fluorescence-activated cell sorting
(FACS) rounds, activated promoters can be identified.
Combining DFI with NGS (termed DFI-seq) is ex-
pected to enable a comprehensive and genome-wide
view of differential gene expression compared to DFI
alone [22], as the DFI-seq principle, as outlined in Fig. 1,
eliminates the need for consecutive sorting of the bacter-
ial library, thereby limiting potential biases associated
herewith.
As with DFI, the bacterial library is exposed to two dif-
ferent environments- the environment under investiga-
tion, and a reference environment used to induce the
expression of housekeeping genes. In DFI-seq however,
the library is grown in parallel in the two respective en-
vironments, followed by isolation of fluorescent bacteria.
The enriched genomic DNA contained in each promoter
trap plasmid is then sequenced and mapped to the
genome. By comparing the number of reads from each
environment it is possible to identify promoters that are
differentially expressed during growth in the two
environments.
By applying DFI-seq on UPEC cultured in human
urine we identify genes encoding hypothetical proteins
as well as genes involved in amino acid biosynthesis to
be differentially expressed in human urine. Five genes
involved in arginine biosynthesis were found to be in-
duced during growth in human urine. Deletion mutants
of these genes exhibit low competition compared to the
wild type during competition assays and demonstrated a
reduced ability to invade or proliferate inside the BEC
line J82. DFI-seq was further applied to UPEC infecting
the BEC line J82 and resulted in the identification of 56
genes that were differentially expressed, including a pre-
viously uncharacterized gene UTI89_C5139, which was
upregulated inside the bladder cells. Deletion of
UTI89_C5139 resulted in an enhanced ability to bind
and invade or proliferate inside cultured BECs.
Madelung et al. BMC Microbiology  (2017) 17:99 Page 2 of 19
Results
Identification of urine-induced genes by DFI
Based on the physiological relevance and experimental
tractability of human urine, we chose this microenviron-
ment as the initial test condition for investigation into
UPEC environment-specific gene expression.
As a reference for validation of DFI-seq, we first used
the established DFI method to identify urine-induced
genes in UTI89. In order to create a promoter trap library,
genomic DNA from E. coli UTI89 was sheared into 500–
700-basepair (bp) fragments and inserted upstream of a
promoterless gfp_ova fusion reporter gene [23] on a
medium copy-number plasmid (pMW82). The resulting
plasmid library, termed pMWLib, was transformed into
commercially available highly competent E. coli MegaX
DH10BTM T1R ElectrocompTM Cells, resulting in approxi-
mately 1.4×105 independent transcriptional fusions, 80%
of which carried an insert. This number corresponds to a
seven-fold genome coverage [22, 24]. The plasmid DNA
library was subsequently purified and used to transform E.
coli UTI89, thereby giving rise to 4×106 independent
transformants. To verify that introduction of the plasmid
library had no inhibitory effect on fitness, the DFI library
was cultured in Lysogeny broth (LB) and compared to
wild type UTI89. Consistent with previous reports [23],
no growth inhibition was observed (data not shown).
Fig. 1 A promoter trap library is created using a gfp gene as reporter. The library is transformed into the bacteria of interest. The pool of
transformants is both used to infect a tissue culture model and grown in vitro. From both environments, green fluorescent bacteria are enriched
using a fluorescence-activated cell sorting instrument and grown over night in vitro. From the two populations plasmids are purified and PCR is
performed to amplify trapped promoters. Through next-generation sequencing, host-induced promoters can be identified by comparing pro-
moter read counts between the two conditions
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UTI89/pMWLib was grown to mid-exponential phase
in human urine followed by FACS-based enrichment of
green-fluorescent bacteria. Next, the sorted bacteria
were grown in LB followed by FACS enrichment of non-
fluorescent bacteria. This two-step cycle was repeated to
enrich for bacterial promoters that were selectively acti-
vated in human urine. After five consecutive sorts, the
resulting bacteria were plated on LB medium to obtain
clonal colonies. The percentage of green-fluorescent bac-
teria in the human urine-cultured bacterial population
increased with every iteration; from 2 to 7.1 to 60.9%
(Table 1).
We analysed the clonal heterogeneity of DFI-enriched
bacteria by restriction fragment length polymorphism
(RFLP) analysis. The RFLP patterns of 192 colonies re-
vealed a high degree of clonal diversity (data not shown).
PCR products amplified from the DNA inserts of 95
RFLP analysed colonies were therefore sequenced. The
sequences could be mapped to 28 genes on the UTI89
genome using BLAST (http://blast.ncbi.nlm.nih.gov/)
(Table 2).
16 genes were identified in two or more colonies. 13
genes were identified in two or more colonies containing
different inserts, for details see Table 2. With the excep-
tion of three, all sequences identified in DFI mapped to
regions upstream of genes.
Not all colonies could be unambiguously assigned to a
unique chromosomal locus on the UTI89 genome. Se-
quences from four colonies each mapped upstream of
two genes. The sequence from colony ID 17 mapped to
a region spanning upstream of ecnA, the ecnA coding se-
quence and upstream of ecnB. The sequence from col-
ony ID 35 mapped 634 nucleotides upstream of asnB
and 215 upstream of manZ. Colony ID 91 mapped 522
nucleotides upstream of UTI89_C1129 and 80 nucleo-
tides upstream of UTI89_4885. Colony ID 41 mapped
554 nucleotides upstream of yaiM and 322 nucleotides
upstream of serA.
Selected DFI-enriched colonies (marked in Bold in
Table 2) were subsequently grown in human urine and
LB to confirm the urine-specific transcriptional induc-
tion. The mean GFP fluorescence from these cultures was
obtained by flow cytometry analysis, and the fold increase
in GFP fluorescence is shown in Table 2. 19 colonies,
representing 21 gene promoters, displayed fluorescence
induction in human urine. The two cultures representing
the metE and metF gene promoters showed highly in-
duced GFP expression in human urine (25.4 and 42.5-fold,
respectively). 12 cultures were upregulated between 3.9
and 14.1-fold, while five cultures showed less than 3-fold
increase in GFP expression. The remaining six cultures,
representing seven gene promoters, displayed either an in-
creased GFP fluorescence level in LB compared to human
urine, no fluorescence in human urine, or no growth in
human urine. These are most likely false-positives result-
ing from erroneous inclusion in the sorted population.
In order to confirm promoter induction, quantitative
real time RT-PCR (RT-qPCR) analysis was employed on
bacterial RNA isolated from UTI89 grown in human
urine and LB. We analysed gene expression in the wild-
type, testing promoter activity independent of the library
clones. The region mapping to the pUTI89 plasmid, and
the region mapping to the opposite stand of yagV was
excluded from RT-qPCR, as GFP expression could not
be verified for these regions. Of the 26 genes included in
the RT-qPCR analysis, 15 genes were shown to be in-
duced significantly in human urine whereas seven were
expressed more strongly in LB compared to human
urine. The four remaining genes could not be placed in
either group (Fig. 2). Thus, out of 26 regions found by
DFI to be differentially expressed during UTI89 growth
in human urine compared to LB, 15 genes were con-
firmed by GFP expression analysis and RT-qPCR (Fig. 2a)
to be upregulated.
Identification of urine-induced genes by DFI-seq
We moved on to perform DFI-seq on UPEC cultured
in human urine. UTI89/pMWLib was grown in hu-
man urine and LB in parallel followed by FACS-
based isolation of green-fluorescent bacteria from
Table 1 DFI sorting overview. Proportion of population enriched by sorting. Sort number 1, 3, and 5 enrich for green fluorescent
bacteria; sort number 2 and 4 enrich for non-fluorescent bacteria
Sort number Original bacterial culture Growth medium Proportion of population
enriched by sorting
1 Original UTI89/pMWLib Human urine 2% (n = 307,176)
2 Fluorescent bacteria isolated during the
1. Sort
LB 20.5% (n = 1,249,036)
3 Non-fluorescent bacteria isolated during the
2. Sort
Human urine 7.1% (n = 401,299)
4 Fluorescent bacteria isolated during the
3. Sort
LB 74.8% (n = 1,733,294)
5 Non-fluorescent bacteria isolated during the
4. Sort
Human urine 60.9% (n = 409,343)
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Table 2 Sequenced inserts, gene name and protein product. UTI89 genome coordinates of identified inserts, and position relative
to proximal genes. Colony identifiers are ordered in accordance to sequence start and end sites. Colonies marked in bold were used
for GFP expression analysis. Differential fluorescence is reported as GFP fluorescence fold change of select UTI89/pMWLib clones
grown in human urine versus LB
Gene Protein Gene
start
Insert
sequence
start
Insert
sequence
end
Colony ID Fold change in
mean GFP signal
argA N-acetylglutamate synthase 3139678 3139160 3139678 8, 57 13.5
3139113 3139736 45
argC N-acetyl-gamma-glutamyl-phosphate
reductase
4439034 4438574 4439108 60 8.2
4438733 4439183 84
argE Acetylornithine deacetylase 4438919 4439100 4438541 4, 93 14.1
4439305 4438787 42
argG Argininosuccinate synthase 3538472 3538296 3538904 51 4.3
3538143 3538627 82
artJ Arginine-binding periplasmic protein 2 861650 862067 861578 16 7.9
asnA asparagine synthetase A 4188023 4187539 4188150 1, 24, 38, 46, 49, 86 1.4
asnB asparagine synthetase B 674199 674321 673791 30 Lower in urine
674541 673908 35
674162 673571 72
manZ PTS system mannose-specific transporter
subunit IID
1930575 1930463 1930677 35 Lower in urine
ecnA entericidin A 4648116 4647814 4648373 17 2.1
ecnB entericidin B 4648352
ilvC Ketol-acid reductoisomerase 4218632 4218651 4219116 20 4.5
4218333 4218799 83
ilvG Acetolacetate synthase 2 catalytic subunit 4211428 4210930 4211421 7, 10 13.8
metA Homoserine O-succinyltransferase 4462506 4462367 4462876 2 2.4
4462142 4462760 9, 11
4462396 4462910 34, 52, 53, 66, 73, 79, 90
4462388 4463001 81
metC Cystathionine beta-lyase 3362694 3362313 3362827 76 2.7
metE 5-methyltetrahydropteroyltriglutamate-
homocysteine S-methyltransferase
4277928 4277452 4277904 6, 26, 67 25.4
4277357 4277878 13, 44, 58, 87
4277611 4278191 74
metF 5,10-methylenetetrahydrofolate reductase 4416931 4416691 4417181 18, 23, 31 42.5
potF putrescine ABC transporter substrate-
binding protein
854834 854439 855001 5 2.4
854460 855009 43
serA D-3-phosphoglycerate dehydrogenase 3236056 3236446 3236125 41 3.9
yaiM hypothetical protein 395196 395661 395108
UTI89_C1129 outer membrane heme/hemoglobin
receptor
1122532 1122106 1122627 91 Lower in urine
UTI89_C4885 hypothetical protein 4787503 4787381 4787460
yajB ACP phosphodieterase 439176 439346 438767 25 Lower in urine
ybdH hypothetical protein 617328 617543 617035 3, 15, 36, 54, 69, 85, 88, 92 9.5
617447 617035 89
617636 617023 21, 50, 56, 77
617691 617083 28, 78
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both samples. In human urine, 2% of the population
was found to be fluorescent; this percentage was 8.1
in LB. We sorted 307,176 events from the human
urine culture and 1,315,930 events from the LB
cultured sample. Sorted populations of green-
fluorescent bacteria were cultured overnight for plas-
mid preparation, followed by PCR amplification of
the inserted DNA segments. The PCR products were
subsequently fragmented into 250–400 bp segments
and prepared for single-end Illumina sequencing
using an in-house protocol [25].
2,269,169 reads from the LB-grown sample and
1,042,702 reads from the human urine-grown sample
were mapped to the UTI89 genome. The average read
Table 2 Sequenced inserts, gene name and protein product. UTI89 genome coordinates of identified inserts, and position relative
to proximal genes. Colony identifiers are ordered in accordance to sequence start and end sites. Colonies marked in bold were used
for GFP expression analysis. Differential fluorescence is reported as GFP fluorescence fold change of select UTI89/pMWLib clones
grown in human urine versus LB (Continued)
617543 617107 61
ybdL aminotransferase 617488 617206 617798 33, 37, 47 5.0
617323 617815 62
yeaR Hypothetical protein 1912199 1912872 1912250 65 6.6
yibI Hypothetical protein 4027446 4027775 4027295 19, 70, 75 5.6
4027590 4027356 68
Unannotated
gene
48649 49106 12, 14, 22, 27, 32, 39, 40, 48,
55, 59, 64, 71, 80, 94, 95
Non-fluorescent
48681 49177 63
Opposite
strand of
yagV
315403 315898 29 Could not be
cultivated in urine
Fig. 2 RT-qPCR verification of differentially expressed genes identified by DFI. RT-qPCR was performed on bacterial RNA isolated from UTI89
grown in human urine and LB, respectively. a and b Expression ratios (log2 scale) of genes differentially expressed in human urine compared to
LB, with P < 0.05. c Gene expression ratios (log2 scale) of uniformly expressed genes (P > 0.05). A pairwise fixed reallocation randomisation test
was performed [45] and exact p-values can be found in Additional file 10: Table S1
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length was 67 bp in both samples and 31.53% of LB cul-
ture reads and 33.79% of the human urine culture reads
uniquely mapped to the UTI89 genome. Promoters were
defined as the region spanning from 300 bp upstream of
the transcription start site (TSS) to 50 bp downstream of
the TSS. Operons were defined as bookended tran-
scripts, i.e. genes with no base pairs separating them.
The number of reads mapping to a defined promoter
was compared between the two growth conditions. 33
genes were identified to be upregulated in human urine
compared to LB, i.e. with a positive regularized logarithm
fold change (rLogFC) [26] of the genes or defined operons
of at least 1.5. 31 genes were identified to be downregu-
lated in human urine compared to LB, i.e. with a negative
rLogFC of the genes or defined operons of −1.5 or less.
Genes and defined operons with an absolute rLogFC of at
least 1.5 are listed in Table 3 (upregulated genes) and
Table 4 (downregulated genes).
The activity of identified promoters, was analysed by
RT-qPCR using bacterial RNA isolated from UTI89
grown in human urine and LB, respectively. Figure 3
shows the expression ratio of all 42 genes analysed. Of
Table 3 rLogFC values for genes upregulated in human urine. BLAST results of hypothetical proteins are represented in parentheses
Genes upregulated during
growth in human urine
compared to LB
Protein Number of
genes in operon
rLogFC
ybdL Aminotransferase 1 2.453653
ybdH Hypothetical protein (oxidoreductase) 1 2.351791
metE 5-methyltetrahydropteroyltriglutamate-homocysteine
S-methyltransferase
1 2.285647
metR DNA-binding transcriptional dual regulator for
metE and MetH
1 2.236911
yjaB Hypothetical protein (acetyltransferase) 1 2.137446
metA Homoserine O-succinyltransferase 1 2.033752
argC;
argB
N-acetyl-gamma-glutamyl-phosphate reductase;
Acetylglutamate kinase
2 2.026239
metF 5,10-methylenetetrahydrofolate reductase 1 2.010415
argE Acetylornithine deacetylase 1 1.957286
ilvY IlvY DNA-binding transcriptional dual regulator 1 1.947862
argD bifunctional N-succinyldiaminopimelate-aminotransferase
/acetylornithine transaminase
1 1.91199
yibI Hypothetical protein 1 1.905502
artJ Arginine-binding periplasmic protein 2 1 1.808872
argG Argininosuccinate synthase 1 1.797071
ilvG;
ilvM
Acetolacetate synthase 2 catalytic subunit; acetolactate
synthase 2 regulatory subunit
2 1.752627
yifB;
UTI89_C4323
predicted ATP-dependent protease;
hypothetical protein
2 1.711417
ydcX Hypothetical protein (membrane protein) 1 1.634447
UTI89_C2996;
UTI89_C2997;
UTI89_C2998;
yfdN1;
UTI89_C3000
bacteriophage V crossover junction endodeoxyribonuclease;
hypothetical protein;
bacteriophage V DNA adenine methylase;
hypothetical protein;
hypothetical protein
5 1.618326
Crl DNA-binding transcriptional regulator Crl 1 1.554786
potF putrescine ABC transporter substrate-binding protein 1 1.529378
metJ transcriptional repressor protein MetJ 1 1.513308
yibH Hypothetical protein (membrane protein) 1 1.511398
UTI89_C2260 Hypothetical protein 1 1.503588
UTI89_C0254;
UTI89_C0255;
UTI89_C0256
Hypothetical protein;
Hypothetical protein (peptidase C39);
Hypothetical protein
3 1.502547
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the 23 genes identified with DFI-seq to be upregulated
in human urine (marked in bold in Table 3), 16 were
confirmed. Of the 19 genes downregulated in human
urine (marked in bold in Table 4), eight were con-
firmed. Three genes (ybaS, nagA and narG) yielded in-
consistent results as they were identified as upregulated
in DFI-seq but downregulated by RT-qPCR. An explan-
ation for this could be that regulatory elements of these
promoters may have been omitted during the DFI li-
brary construction.
Twelve of the 15 genes identified by DFI were also
identified in DFI-seq. In Fig. 4, a Venn diagram showing
the extensive overlap of the DFI and DFI-seq results, is
presented. DFI-seq yields a larger set of unique gene
identifications compared to DFI. It further allows for
identification of upregulated as well as downregulated
promoters in the same experiment, thus providing a
more comprehensive overview of changes in the tran-
scriptional activity during bacterial growth in human
urine vs. LB.
Functional assessment of urine-induced UPEC genes
A total of 18 genes from both screens were selected for
functional investigation. The 18 genes were deleted using
the Lambda-Red-mediated recombination method devised
by Datsenko and Wanner [27]. Two thirds of the selected
Table 4 BLAST results of hypothetical proteins are represented in parentheses
Genes downregulated during
growth in human urine compared to LB
Protein Number of
genes in operon
rLogFC
fliF;
fliG;
fliH;
fliI
flagellar MS-ring protein;
flagellar motor switch protein G;
flagellar assembly protein H;
flagellum-specific ATP synthase
4 2.177048
fliE flagellar hook-basal body protein FliE 1 2.158562
UTI89_C3136 Hypothetical protein
(FAD-linked oxidoreductase)
1 1.979745
ybeK Hypothetical protein (hydrolase) 1 1.857649
nadC quinolinate phosphoribosyltransferase 1 1.789156
nagA N-acetylglucosamine-6-phosphate deacetylase 1 1.739815
menE;
menC;
menB
O-succinylbenzoic acid-CoA ligase;
O-succinylbenzoate synthase;
naphthoate synthase
3 1.731787
galS DNA-binding transcriptional regulator GalS 1 1.715122
UTI89_C0374 Hypothetical protein
(nucleoprotein/polynucleotide-associated enzyme)
1 1.701595
fadB multifunctional fatty acid oxidation complex subunit alpha 1 1.682517
ampD;
ampE
N-acetyl-anhydromuranmyl-L-alanine amidase;
regulatory protein AmpE
2 1.671218
narG;
narH;
narJ;
narI
respiratory nitrate reductase 1 subunit alpha; respiratory
nitrate reductase 1 subunit beta;
nitrate reductase 1 subunit delta;
nitrate reductase 1, cytochrome b(NR) subunit gamma
4 1.630201
lacI lac repressor 1 1.604708
pepQ;
yigZ
Proline depeptidase;
hypothetical protein
2 1.580097
yiiM Hypothetical protein
(6-N-hydroxylaminopurine resistance protein)
1 1.559754
yjeM Transporter YjeM 1 1.536508
purC phosphoribosylaminoimidazole-succinocarboxamide
synthase
1 1.528491
ynfK dithiobiotin synthetase 1 1.508037
ybaS Glutaminase 1 1.507194
hlyA hemolysin A 1 1.50293
ybaR copper-transporting P-type ATPase 1 1.501551
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genes are known to be directly or indirectly involved in
amino acid metabolism, exceptions being potF, ybdH,
ybdL, yeaR, yibI and yjaB. The potF and ybdL genes en-
code putrescine ABC transporter substrate-binding pro-
tein and an aminotransferase respectively; the remaining
four genes all encode hypothetical proteins. By BLAST
analysis these were predicted to encode an oxidoreductase
(ybdH), proteins of unknown function (yeaR and yibI),
and an acetyl transferase (yjaB).
To assess the effect of deletion mutations on UTI89
fitness in human urine, competition assays were
employed. The 18 mutant strains were grown in human
urine in a 1:1 ratio with the UTI89 wild type. After 24 h,
15 of the mutants were significantly outcompeted to
varying degrees (Fig. 5a).
All mutants affected in L-arginine biosynthesis were
outcompeted during growth in human urine. The argA,
argB, argC, argE and argG mutants had competitive in-
dexes (CIs) of only 0.12, 0.02, 0.11, 0.14 and 0.000007,
respectively. For genes involved in methionine biosyn-
thesis the CIs were 0.19 (metA), 0.06 (metE), 0.03 (metF)
and 0.15 (metR). Other genes directly or indirectly in-
volved in amino acid metabolism were important for fit-
ness, displaying CIs of 0.11 (artJ and serA) and 0.15
(ilvG). Mutants in yeaR or yjaB, two genes with un-
known function, the CIs were 0.37 for both, and for the
yibI mutant it was 0.33. Disruption of potF, ybdH and
ybdL did not result in a statistically significant fitness de-
fect (Additional file 1: Figure S1).
Urine is the environment encountered by UPEC before
invasion of BECs and it is therefore reasonable to inves-
tigate whether the 18 genes might have an influence on
the invasion or intracellular proliferation of UTI89 in
Fig. 3 RT-qPCR verification of differentially expressed genes identified in the DFI-seq experiment. RT-qPCR was performed on bacterial RNA isolated from
UTI89 grown in human urine and LB, respectively. a and b Expression ratios (log2 scale) of genes differentially expressed in human urine compared to LB,
with P< 0.05. c Gene expression ratios (log2 scale) of uniformly expressed genes (P> 0.05). A pairwise fixed reallocation randomisation test was performed
[45] and exact p-values can be found in Additional file 11: Table S2
Fig. 4 Area-proportional Venn-diagram demonstrating the overlap
between DFI and DFI-seq results. Genes included were all confirmed
by RT-qPCR
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BECs. The BEC-line J82 was infected with wild type
UTI89 or mutant strains at a multiplicity of infection
(MOI) of 100. After gentamicin-protection assays in-
tracellular survival was evaluated. All null mutants af-
fected in L-arginine biosynthesis showed an attenuated
ability to invade BECs along with UTI89ΔmetA (Fig. 5c).
The remaining mutants showed no statistically signifi-
cant difference in their ability to invade the J82 BECs
(Additional file 2: Figure S2).
We investigated whether the reduction in intracellu-
lar bacterial counts of the metA and arg mutants was
due to impaired BEC adhesion. Among the null mu-
tants affecting L-arginine biosynthesis, only the ΔargE
mutant displayed a reduced adhesion capacity. In
addition to argE, the deletion of five other genes re-
sulted in reduced adherence to BECs, metE, metF,
serA, ybdH, and yibI (Fig. 5b). The remaining mutants
showed no statistically significant difference in their
ability to adhere to the J82 BECs (Additional file 3:
Figure S3).
Identification of BEC-induced UTI89 genes using DFI-seq
Having validated the use of DFI-seq in human urine we
next moved on to employ the method on infected blad-
der cells. The J82 BEC line was infected with the UTI89
promoter trap library at an MOI of 10 and as control
the library was grown simultaneously in DMEM media.
The low MOI was used to minimize the incidence of
single-cell invasion by multiple non-clonal bacteria. The
two samples were subjected to FACS-based isolation of
green-fluorescent BECs or bacteria, respectively.
In DMEM medium, 2.6% of the population was found
to be fluorescent and in the BEC sample this percentage
was 0.4%. From the BEC sample 4,320 events were
sorted, whereas 193,105 events were sorted from the
bacterial sample. 10,736,670 reads from the BEC sample
and 14,820,780 reads from the bacterial sample were
mapped to the UTI89 genome. The average read length
was 50 bp in both samples, and the fraction uniquely
mapping to the UTI89 genome was 60.93 and 69.65%,
respectively.
Fig. 5 Fitness and relative cell adhesion and invasion of select deletion mutants. a Competitive index of deletion mutants during growth in
human urine. The standard error of the mean of two independent 24-h growth experiments is shown (P < 0.05), the exact p-value can be
seen in Additional file 7: Additional file 7: Table S3. b Mutants with statistically significant (P < 0,05) adhesion defects to J82 cells, the exact
p-value can be seen in Additional file 9: Table S4. c Mutants with statistically significant (P < 0,05) invasion defects the exact p-value can be
seen in Additional file 8: Table S5. The standard error of the mean of three independent assays is shown. a, b and c Unpaired t tests with
two-tailed p-values were performed using GraphPad Prism 5 software
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Table 5 UTI89 genes upregulated in J82 BECs. BLAST results of hypothetical proteins are represented in parentheses
Genes upregulated during growth in J82 BECs Protein Number of genes in operon rLogFC
trpR Trp operon repressor 1 2,332854642
yaaU metabolite transport protein YaaU 1 2,283687208
UTI89_C4979 hypothetical protein (Transposase) 1 2,249895676
UTI89_C4140 hypothetical protein 1 2,15066842
rluA 23S rRNA/tRNA pseudouridine synthase A 1 2,07065298
pepQ;
yigZ
Proline dipeptidase;
hypothetical protein
2 1,975901548
UTI89_C5123; UTI89_C5124 tail component of prophage CP-933 K;
tail component of prophage CP-933 K
2 1,86063772
lplA lipoate-protein ligase A 1 1,852945008
yceI hypothetical protein 1 1,840726794
UTI89_C5140 hypothetical protein 1 1,83941429
UTI89_C5136 hypothetical protein (putative membrane protein) 1 1,837077447
UTI89_C5163 hypothetical protein (transcriptional regulator) 1 1,72527562
UTI89_C5093 hypothetical protein (Phytoene synthase) 1 1,701749646
yfdQ2 hypothetical protein (phage protein) 1 1,699919702
deoA thymidine phosphorylase 1 1,698786977
UTI89_C5087; UTI89_C5088 hypothetical protein (phage protein);
hypothetical protein (HNH endonuclease)
2 1,689083782
UTI89_C0227 LysR family transcriptional regulator 1 1,666994808
yjjJ hypothetical protein
(transcriptional regulator)
1 1,659851375
UTI89_C5141 hypothetical protein 1 1,65493764
yjjK ABC transporter ATP-binding protein 1 1,65080455
deoB;
deoD
Phosphopentomutase;
purine nucleoside phosphorylase
2 1,637364571
UTI89_C5086 hypothetical protein
(putative membrane protein)
1 1,619322431
yecH hypothetical protein 1 1,607068129
yafD hypothetical protein
(EEP domain-containing protein)
1 1,587086745
UTI89_C5108 hypothetical protein 1 1,572251909
Slt lytic murein transglycosylase 1 1,55866374
UTI89_C5139 hypothetical protein 1 1,551006847
UTI89_C5078 hypothetical protein 1 1,539466639
osmY periplasmic protein 1 1,536342614
UTI89_C5146 hypothetical protein (membrane protein) 1 1,529533673
yjjU;
yjjV
hypothetical protein (phospholipase);
deoxyribonuclease YjjV
(metal-dependent hydrolase)
2 1,525815587
dnaC DNA replication protein DnaC 1 1,525438036
UTI89_C3195 hypothetical protein 1 1,510078684
yjjM hypothetical protein
(GntR family transcriptional regulator)
1 1,504013167
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The number of reads mapping to a defined promoter
was compared between the two samples, leading to the
identification of 34 promoter regions upregulated inside
BECs with a positive rLogFC of at least 1.5. 16 promoter
regions were identified to be downregulated inside BECs
with a negative rLogFC of −1.5 or less. Genes and de-
fined operons with an absolute rLogFC of at least 1.5 are
listed in Table 5 (upregulated genes) and Table 6 (down-
regulated genes).
Among the 16 downregulated regions, six were placed
on the UTI89 plasmid (marked in bold in Table 6). One
of the plasmid-encoded genes encodes a product with
known function; repB, is involved in controlling plasmid
replication. Of the ten downregulated chromosomally
encoded genes, four encode hypothetical proteins. 23
out of 39 upregulated genes encode hypothetical pro-
teins, ten of which could not be assigned by BLAST to a
protein function or a cellular location.
One gene was chosen for further investigation to show
that validity of the method for identification of genes in-
volved in invasion. UTI89_C5139 was deleted from the
UTI89 chromosome and tested for cell adhesion and in-
vasion using the BEC-line J82 at an MOI of 100 (Fig. 6).
The UTI89_C5139 mutant displayed a significant in-
crease of 25% in both cellular adhesion and invasion.
The amino acid sequence (Uniprot; Q1R275-1) of the pro-
tein encoded by UTI89_C5139 was analysed for presence
Table 6 UTI89 genes downregulated in J82 BECs. BLAST results of hypothetical proteins are represented in parentheses. Genes
located on the UTI89 plasmid are marked in bold
Genes downregulated during growth in J82
BECs
Protein Number of genes in
operon
rLogFC
repB replication protein 1 2,011113132
htgA positive regulator for sigma 32 heat shock promoters 1 1,890514455
UTI89_P010 hypothetical protein (iron permease/transporter (membrane
protein))
1 1,861559188
ribF bifunctional riboflavin kinase/FMN adenylyltransferase 1 1,859516233
yaaY hypothetical protein 1 1,848940285
ydiA hypothetical protein 1 1,753697215
gyrB DNA gyrase subunit B 1 1,74780503
rob right origin-binding protein 1 1,738152589
yajK thiamine biosynthesis protein ThiI 1 1,638543917
creA hypothetical protein (protein CreA (Catabolite regulation
protein A))
1 1,635400678
ytfB hypothetical protein (Opacity-associated protein A) 1 1,617894201
UTI89_P053 hypothetical protein 1 1,614324659
yjjX NTPase 1 1,60329406
UTI89_P144 hypothetical protein (putative endonuclease) 1 1,577892223
yccW hypothetical protein (ribosomal RNA large subunit
methyltransferase)
1 1,516636602
UTI89_P046; UTI89_P047 hypothetical serine-threonine protein kinase
hypothetical protein
2 1,513872693
Fig. 6 Cell adhesion and invasion of UTI89ΔC5139. The standard
error of the mean of a minimum of three independent assays is
shown for both adhesion and invasion. P-values are indicated above
columns. An unpaired t test with two-tailed p-values was performed
using GraphPad Prism 5 software
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of transmembrane helices using the TMHMM program
(http://www.cbs.dtu.dk/services/TMHMM/) and was
found to contain one transmembrane helix near the N-
terminal suggesting the protein could be located in the
outer membrane. Of the remaining 22 hypothetical genes
found to be upregulated, four encode proteins that were
found to contain transmembrane helices (Additional file
4: Table S6). Three of these proteins were by BLAST
found to be putative membrane proteins (Table 5).
UTI89_C5136, UTI89_C5146 and UTI89_C5068 have
four, two and four transmembrane helices respectively.
The remaining gene UTI89_C5140 encodes a protein
which contains a single transmembrane helix located near
the N-terminal. UTI89_C5140 is located 53 bases down-
stream from UTI89_C5139 on the same strand, suggesting
that these two genes might be transcribed simultaneously
during infection.
Discussion
The knowledge about UPEC fitness and virulence gene
expression in the urinary tract is far from complete and
with the emergence of multidrug-resistant (MDR) UPEC
strains, limiting the available treatment options, new
strategies are necessary to prevent UTIs [28]. A deeper
understanding of UPEC adaption to the urinary tract, its
fitness and pathogenicity would help in the search for
new treatment or prevention options.
Gene expression is usually investigated by microarray
analysis or, in recent years, by RNA-seq. By measuring
specific RNA levels, both methods can give a genome-
wide view of gene expression in a bacterial population.
Both methods have been used on urine samples from
patients with UTIs [29, 30]. However, when investigating
infected tissue limitations arise. RNA purification of
mixed samples results in an overwhelming amount of
eukaryotic RNA that will diminish the information con-
tent that can be derived from the bacterial RNA by con-
ventional approaches [31].
Another way to study environment-specific gene induc-
tion is by screening promoter trap libraries, which circum-
vents the need for RNA purification. It can be done using
a conditionally essential reporter gene as done in in vivo
expression technology (IVET) or a fluorescence marker as
done in DFI [22]. IVET identifies genes that are constitu-
tively and highly expressed. However, this method fails to
detect transiently or weakly expressed genes, a limitation
that was overcome with the introduction of the DFI
method [32]. DFI and DFI-seq are not biased by the abso-
lute expression levels of the selectable marker, and weakly
and highly fluorescent clones are therefore sorted with
equal efficiency. The DFI strategy is based on consecutive
rounds of FACS based on differential GFP expression. The
gfp gene has been replaced by a gfp_ovalbumin (gfp-ova)
gene fusion [22], which encodes a destabilized GFP-
Ovalbumin reporter fusion with less impact on bacterial
fitness. This also enables examination of the active pro-
moters in an environment at a specific time point, giving a
snapshot of the activated genes. Both IVET and DFI only
identify upregulated genes and eliminate housekeeping
genes from the promoter trap library. In DFI this is
achieved during the consecutive sorts. These consecutive
sorts are time consuming and can introduce bias, however
too few sorts can give to many false positive gene
identifications.
In the previous DFI studies conducted by Valdivia et
al. [21, 32] only three consecutive sorts were used. Here
we used five sorting steps in order to reduce the number
of false-positives (Table 1). Of the 25 clones picked for
the confirmation of urine-specific GFP induction, 76%
had a higher fluorescence in human urine compared to
LB (Table 2). The induction of gene promoters measured
by GFP-Ovalbumin protein, was confirmed using RT-
qPCR. However, the increase in mean GFP fluorescence
(Table 2) does not accurately reflect the change in
mRNA level for a particular promoter (Fig. 2). During
insertion of DNA fragments into the promoter trap plas-
mid, we may inadvertently have altered promoter activ-
ity, for example by excluding transcription factor
binding sites from the inserted fragment.
By introducing DFI-seq, we attempt to simplify the
DFI method and at the same time harness the power of
NGS to generate genome-wide rather than clonal data.
DFI-seq eliminates the need for consecutive sorting of
the bacterial library, and thereby limits the bias that can
be introduced. The method however can introduce bias
due to overnight growth of the sorted bacteria, as with
DFI, and when PCR amplifying the promoters before
NGS. However, the method can identify both up- and
downregulated genes in a single sorting step. The data
from DFI and DFI-seq largely overlap, thus validating
the use of the DFI-seq method over traditional DFI. By
reducing bias DFI-seq diminishes the chance for gener-
ation of false-positive identifications. To increase the
stringency of DFI-seq experiments and reduce the
chances of generating false positives due to the biases
that might be introduced, biological replicates should be
included in the DFI-seq experiments. However, the pos-
sibility of excluding transcriptional factor binding sites
still exist and DFI-seq should therefore be considered
mainly as a qualitative discovery tool that requires RT-
qPCR for quantitation of individual promoter outputs.
Human urine contains few amino acids and these
serve as the main carbon source for bacteria growing in
the urinary tract [33]. Biosynthesis of amino acids can
therefore be considered a fitness factor for UPEC during
UTI. Our results support this view, as 55% of the 22
genes confirmed by RT-qPCR to be upregulated in
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human urine (Figs. 2 and 3) were directly or indirectly
involved in amino acid biosynthesis.
Serine and methionine biosynthesis have previously
been reported to be necessary for optimal fitness of
UPEC in human urine [34] and our observations were in
accordance to this. The serA gene encodes D-3-
phosphoglycerate dehydrogenase. This enzyme uses
NAD+ in the conversion of 3-phospho-D-glycerate to 3-
phosphohydroxypyruvate as a first step in serine biosyn-
thesis [35]. In RT-qPCR the serA gene had an expression
ratio of 2.3 (Fig. 2a), corresponding to an almost five-
fold upregulation during growth in human urine com-
pared to LB. This is in agreement with the findings by
Alteri et al., which identified differentially expressed pro-
teins in UPEC strain CFT073 during growth in human
urine and iron-limited LB by comparative proteomics
[20]. The serA null mutant was inhibited in its ability to
adhere to J82 BEC (Fig. 5b) by about 60% compared to
the wildtype, and displayed a CI of 0.11 during growth
in human urine (Fig. 5a). We did not detect a significant
difference between wildtype UTI89 and UTI89ΔserA
during invasion of BEC-line J82. Alteri et al. showed that
a serA mutant of UPEC strain CFT073 was not signifi-
cantly out-competed by wild type CFT073 in vivo 48 h
post infection of mice [20] and the mutant suffered only
a slight fitness defect. These results taken together sug-
gest that the effect of the serA gene is mainly related to
growth in urine prior to host cell invasion.
Genes involved in methionine biosynthesis, metA,
metE, metF and metR genes were found to be upregu-
lated in human urine (Fig. 3a), while metC was downreg-
ulated (Fig. 2b). The metA, metC and metE genes
encode enzymes involved in methionine biosynthesis;
metE is positively regulated by the MetR DNA-binding
transcriptional dual regulator. The metF gene is indir-
ectly involved in methionine biosynthesis. MetF is in-
volved in the biosynthesis of 5-methyltetrahydrofolate,
which acts as a substrate for methylation in the last step
of methionine biosynthesis in a reaction catalysed by
MetE. Deletion mutants of metA, metE, metF and metR
were all less competitive than the wild type during
growth in human urine. The metE and metF mutants
displayed reduced adhesion to J82 BECs (Fig. 5a), while
the metA mutant was inhibited in its ability to invade or
proliferate intracellularly in J82 BECs (Fig. 5b). Thus,
our results are consistent with the findings of Hull and
Hull [34] in showing that Methionine biosynthesis is im-
portant for UPEC fitness in urine and that mutations af-
fecting this process can affect the virulence of UPEC,
thereby connecting fitness genes to virulence.
Two additional amino acids, whose biosynthesis is im-
portant during growth in human urine, are isoleucine
and arginine [36]. We found that the ilvG mutant was
less competitive than the wild type (CI = 0,15) and that
ilvG was upregulated during growth in human urine
(Expression ratio (log2) of 6.65). The ilvG and ilvM
genes encode the catalytic and regulatory subunit of
acetolactate synthase 2, respectively. This enzyme uses
pyruvate as a substrate during isoleucine biosynthesis.
We did not detect differential expression of ilvC, which
encodes another enzyme in isoleucine biosynthesis, was
differentially regulated in human urine compared to LB
(Fig. 2c). This gene has been reported by Snyder et al. to
be upregulated in UPEC strain CFT073 during growth
in human urine [36].
We analysed deletion mutants in six genes involved in
arginine metabolism. The artJ gene encodes the
Arginine-binding periplasmic protein 2, which is part of
the Arginine ABC transport system. This system is com-
posed of five proteins encoded by the artP, artI, artQ,
artM and artJ genes, all located in succession on the
UTI89 chromosome. The artJ null mutant was outcom-
peted in human urine by the wild type (CI = 0,11), how-
ever it was not significantly compromised in is ability to
adhere to and invade or proliferate inside J82 BECs.
Consistent with our findings, artJ was previously shown
to be upregulated during growth on human urine agar
plates [37], and upregulated in human urine [36].
Of the five arg genes investivated argC, argE and argG
was confirmed by RT-qPCR to be upregulated. argG was
previously found to be up-regulated in human urine
compared to iron-limited LB [20], and a DNA micro-
array study on UPEC strain CFT073 found argB, argC
and argE to be upregulated in human urine [36]. All mu-
tants affected in L-arginine biosynthesis were outcom-
peted during growth in human urine (Fig. 5a), consistent
with previous findings [34]. In urine, arginine is present
at a suboptimal level for bacterial growth [34]. This
could be the reason behind this requirement for
endogenous synthesis of arginine in this extracellular en-
vironment. Arginine biosynthesis mutants were all inhib-
ited in their ability to invade or proliferate inside J82
BECs (Fig. 5c) but only the argE mutant displayed re-
duced adhesion ability (Fig. 5b). CFT073ΔarG has been
shown to resist out-competiton by CFT073 wild type in
vivo 48 h post infection of mice [20]. The results how-
ever indicated a slight fitness defect in the kidneys but
not the bladder. Another study showed that an argC
mutant had a significantly decreased ability to infect the
mouse kidney [38]. Taken together these results demon-
strate a significant link between amino acid biosynthesis
and virulence, and hence support the recent bacterial
virulence paradigm suggested by Mobley [19]. Using
growth competition assays, we show that the arg genes
contribute to the fitness of UPEC in urine. However,
these genes also play a role in the intracellular UPEC
proliferation without affecting their initial adhesion to
host cells. Thus, the arg genes are not only fitness
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factors but also virulence determinants enabling IBC for-
mation - a charateristic of UPEC pathogenesis. The cap-
acity for biosynthesis of specific amino acids may
become critical during intracellular bacterial growth. In
support hereof, the amino acid requirements of Salmon-
ella enterica for intracellular proliferation have been
shown recently to vary according to the infected cell
type [39].
Yet another gene found in our study links back to ar-
ginine and methionine, potF. The potF gene encodes a
substrate-binding protein, which is part of the ABC
transporter of the polyamine putrescine. The predomin-
ant polyamines in bacteria are putrescine and spermi-
dine. Arginine can be converted into putrescine and
further into Spermidine [39]. Polyamines were found to
be important for virulence in Salmonella as a polyamine
mutant of Salmonella Typhimurium had a reduced
intracellular survival/replication compared to the wild
type and was attenuated in the mouse model of typhoid
fever [39]. Thus, polyamines may serve as environmental
cues for the bacteria to initiate virulence gene expression
[39]. UPEC potF has been shown by microarray analyses
to be downregulated in response to increased environ-
mental osmolality caused by high salt and urea [40] and
when isolated from the urine of infected women [30].
Our data showed that potF was upregulated in human
urine compared to LB, but deletion had no effect on cell
invasion. The ABC transporter affected in the potF dele-
tion mutant is not the only ABC transporter capable of
transporting putrescine, possibly explaining why we do
not observe an effect on UPEC virulence in the potF
mutant.
To demonstrate the usefulness of DFI-seq in a more
complicated experimental setup, BECs were infected
with UPEC strain UTI89 and subjected to DFI-seq. Of
the 56 genes found to be differentially expressed in the
BECs, almost 60% encoded hypothetical proteins. These
may possibly represent virulence factors not yet discov-
ered. To validate the DFI-seq method one gene was
chosen for further investigation. The UTI89_C5139 gene
encodes a putative membrane protein, which contains a
transmembrane domain. The deletion mutant exhibited
increased adherence to J82 BECs and increased invasion
or intracellular proliferation. UTI89_C5139 was found
during DFI-seq to be upregulated during invasion, and a
deletion mutant of this gene was expected to be less
invasive in ex vivo experiments. The opposite was ob-
served, indicating that the gene product directly or
indirectly influences the expression of other virulence
genes, possibly limiting their effect to avoid immune
system detection or a to high infection rate that
might lead to premature exfoliation of the bladder
lining both resulting in a lowering of the bacterial
burden.
Conclusion
DFI-seq allowed the positive selection of genes involved
in UPEC growth in vitro in human urine as well as
during infection of bladder tissue culture. DFI-seq pro-
vides a more comprehensive overview of differential
gene expression than conventional DFI, it is less time-
consuming and labor-intensive and has fewer handling
steps that may introduce bias. We identified genes in-
volved in amino acid metabolism necessary for growth
in human urine compared to growth in LB by using
DFI-seq. The arginine biosynthesis genes were found to
be required for successful infection of BECs, thus
strengthening the assertion that fitness and virulence
gene expression are both important in UPEC pathogen-
icity. DFI-seq provides a new avenue for virulence and
fitness gene identification using positive selection and
we show that it can be used not only with liquid culture
but also in cell culture assays. In order to firmly establish
a definite role in virulence of the genes identified in this
study, animal infection experiments are required. Thus,
DFI-seq should be applicable to in vivo infection sys-
tems, thus providing important insights into host-
induced changes in gene expression of infecting bacterial
pathogens.
Methods
Bacterial strains, cells, and growth conditions
The UPEC strain UTI89, a cystitis-derived isolate [5]
was used for library construction. UTI89-derived dele-
tion mutants (Table 7) were constructed using the
lambda Red recombination [27]. Primers used for mu-
tant construction can be found in Additional file 5: Table
S7. Additionally, E.coli DH5α was used as a non-
pathogenic control strain.
Bacterial cultures were grown at 37 °C in LB medium,
DMEM+ 10% FBS, or human urine (USG 1.021) con-
taining 30 μg/mL chloramphenicol (cml), 50 μg/mL
kanamycin (kan) or 100 μg/mL ampicillin (amp) for
plasmid selection. Human urine was prepared for experi-
ments as described previously by Andersen et al. [41].
J82 BECs (ATCC® HTB-1™) were maintained at 5%
CO2, as a monolayer in DMEM (ThermoFisher Scien-
tific) containing 10% (v/v) heat-inactivated fetal bovine
serum (FBS) (Gibco) and Penicillin (100 units/ml)-
Streptomycin (100 μg/ml) (Gibco).
Library construction
The UTI89 promoter trap library was constructed as de-
scribed by Bumann and Valdivia [22] with minor modifi-
cations. Chromosomal DNA was purified from an
overnight culture of UTI89. Bacterial cells were har-
vested and resuspended in TE buffer (0.089% Trizma
hydrochloride (w/v), 0.053% Trizma base (w/v) and
0.1 mM EDTA), rapid lysis buffer (5% sodium dodecyl
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sulfate (SDS), 0.125 M EDTA, 0.5 M Tris–HCl pH 9.4),
Ribonuclease A (Sigma Aldrich) and protease (Roche)
(37 °C) and incubated for 1 h at 37 °C. Chromosomal
DNA was purified by phenol-chloroform extraction, pre-
cipitated by addition of 2 vol. 96% ethanol, and resus-
pended in TE-buffer.
Purified genomic DNA (100 ng/ml) was disrupted by
sonication for 2×30 s using a Branson Sonifier 250
(Branson Ultrasonics). Resulting fragments of 500–
700 bp were purified from a 2% agarose gel using a GFX
PCR DNA and Gel Band purification kit (GE Healtcare)
and treated with T4 polymerase (New England Biolabs)
for 15 min at 12 °C to repair single-stranded regions.
The library vector pMW82 was cleaved with BamHI
(Fermentas) and SphI (Fermentas), and treated with T4
polymerase to fill in single-stranded overhangs. Next,
treatment with shrimp alkaline phosphatase (USB Cor-
poration) was included to prevent vector re-ligation. Fi-
nally, genomic fragments and vector DNA was ligated
using T4 DNA ligase.
Ligated DNA was introduced into MegaX DH10BTM
T1R ElectrocompTM Cells (Invitrogen) by electropor-
ation, and transformants were selected by plating on LB
agar containing 100 μg/ml amp. The frequency of vector
re-ligation was estimated to be less than 20%. Plasmids
were subsequently purified using NucleoBond AX kit
(Macherey-Nagel) and transformed into E. coli UTI89 by
electroporation. The resulting amp-resistant colonies,
together constituting the promoter trap library UTI89/
pMWLib, were pooled and frozen at −80 °C.
Sorting and FACS analysis of bacterial cells
Bacterial cells were grown to mid-exponential phase (4–
5 generations) at 37 °C with aeration in preheated LB or
human urine (USG 1.021) with 100 μg/ml ampicillin or
for 1 h without aeration in preheated DMEM with 10%
FBS. For DFI analysis of UTI89/pMWLib, bacteria
grown in urine were sorted based on green fluorescence
and bacteria grown in LB were sorted based on the ab-
sence of green fluorescence. In DFI-seq, fluorescent bac-
teria were sorted for all growth conditions, LB, human
urine and DMEM. The bacteria were then collected by
centrifugation at 3500xg for 10 min, resuspended in LB
and grown overnight.
Sorting and FACS analysis of BECs
J82 grown to confluence in 15 cm dishes or 6-well plates
were infected at an MOI of 10 for 1 h at 37 °C. The cells
were then washed three times with PBS to remove non-
invading bacteria and incubated in DMEM with 10%
FBS and 100 μg/ml gentamicin for 2 h. Next, infected
cells were washed three times with PBS to remove the
gentamicin before 0.25% trypsin-EDTA was added for
5 min to release the cells into suspension. The cells were
Table 7 Bacterial strains and plasmids used in this study
Strain Genotype Source
UTI89 Serotype O18:K1:H7 [5] Provided by
Emile Van Schaftingen
UTI89/
pMW82
AmpR This study
UTI89/
pMWLib
AmpR This study
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF)
U169 recA1 endA1 hsdR17
(rK–, mK+) phoA supE44 λ– thi-1
gyrA96 relA1
Invitrogen
UTI89ΔargC
ΔargC, CmlR This study
UTI89ΔargE ΔargE, CmlR This study
UTI89ΔargG
ΔargG, CmlR This study
UTI89ΔartJ ΔartJ, CmlR This study
UTI89ΔilvG ΔilvG, CmlR This study
UTI89ΔmetA
ΔmetA, CmlR This study
UTI89ΔmetE
ΔmetE, CmlR This study
UTI89ΔmetF
ΔmetF, CmlR This study
UTI89ΔpotF ΔpotF, CmlR This study
UTI89ΔybdH
ΔybdH, CmlR This study
UTI89ΔybdL
ΔybdL, CmlR This study
UTI89ΔyibI ΔyibI, CmlR This study
UTI89ΔargA
ΔargA, CmlR This study
UTI89ΔserA ΔserA, CmlR This study
UTI89ΔyeaR
ΔyeaR, CmlR This study
UTI89ΔargB ΔargB, CmlR This study
UTI89ΔmetR
ΔmetR, CmlR This study
UTI89ΔyjaB ΔyjaB, CmlR This study
UTI89ΔC5139
ΔC5139, KanR This study
Plasmid Genotype Source
pKD3 Cml template plasmid [28]
pKD4 Kan template plasmid [28]
pKD46 Bla, λ Red recombinase
expression plasmid
[28]
pMW82 [22] Kindly provided
by Dirk Bumann
pMWLib pMW82 containing random
500−700 bp long UTI89
DNA segments
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collected by centrifugation at 150 ×g and 4 °C for
10 min and resuspended in PBS containing 10% FBS.
J82 cells emitting green fluorescence were collected by
cell sorting, using a FACSAria II. In order to preserve
the samples, cell sorting was performed for a maximum
of 1 h per sample, so several infection assays were set up
to allow for successive sorting of multiple samples. Fi-
nally, bacteria were released from the J82 cells by
addition of 1% Triton X-100 and vortexing for 60 s. The
bacteria were then collected by centrifugation at 3500×g
for 10 min, resuspended in LB and grown overnight.
Sequencing and analysis of sequence data after DFI
Following FACS-based enrichment, the bacterial cells
were plated on LB agar with 100 μg/ml amp and grown
overnight at 37 °C. Resistance Fragment Length Poly-
morphisms (RFLP) patterns [22] were analysed by agar-
ose gel separation. 95 colonies were sequenced using
primers P1 (5′-TGAAGGCTCTCAAGGGCATC-3′)
and P2 (5′-GTGTTGGCCATGGAACAGGT-3′). Se-
quences were aligned, using BLAST, with the E. coli
UTI89 chromosome and pUTI89 sequences (NCBI data-
base accession number NC007946 and NC007941). Anno-
tation of fragments was performed using Ecocyc.org [42].
Quantitative real time RT-PCR
Primers for RT-qPCR listed in Additional file 6: Table S8
were designed using Primer3 software [43, 44]. Total
RNA was isolated by phenol/chloroform extraction from
UTI89/pMW82 grown to mid-exponential phase (4–5
generations) at 37 °C with aeration in LB and human
urine (USG 1.021), respectively. 1 μg of total RNA was
treated with DNase I for 30 min at 37 °C, followed by
heat inactivation of the enzyme. Purified RNA was then
used for cDNA synthesis using the Maxima first strand
cDNA synthesis kit (Thermo Scientific). Real time quan-
tification was performed using SYBR® Select Master Mix
(Life Technologies) as specified by the manufacturer.
RT-qPCR reactions were run in 96-well plates in an
Mx3005P QPCR System (Agilent Technologies) using
rrsA and rpoB mRNA as internal controls. Measure-
ments were performed in at least three technical repli-
cates to enable determination of the relative fold change
in mRNA expression between UTI89 grown in urine
and LB [45].
Sequencing and analysis of sequence data after DFI-seq
Plasmids were purified from sorted UTI89/pMWLib using
NucleoBond PC 500 kit (Macherey-Nagel) as specified by
the manufacturer. PCR amplification of the inserted
chromosome segments in pMWLib was performed using
primers P1 (5′-TGAAGGCTCTCAAGGGCATC-3′) and
P2 (5′-GTGTTGGCCATGGAACAGGT-3′). For Illumina
sequencing, the DNA fragments were sonicated into 250–
400 bp long segments from the original size of 500–
700 bp, and sequencing library preparation was performed
according to the manufacturer’s instructions (Illumina) as
described previously [25]. The library was sequenced
using the Illumina HiSeq 1500 instrument.
Reads were aligned using STAR version 2.3.1z_r395
with spliced mapping disabled. Subsequently, uniquely
aligning reads overlapping operon promoters were
counted, and DESeq2 was used to identify promoters
that were utilized differentially in the urine sample. The
rLogFC was calculated. A positive rLogFC means that
more reads map to a particular operon promoter region
in the sample grown in human urine compared to LB.
The opposite is true of a negative score. Operon pro-
moters were defined as the region spanning from 300 bp
upstream of the transcription start site to 50 bp down-
stream. Operons were defined as bookended transcripts,
i.e. genes with no base pairs separating them.
Competitive index
The fitness of single-gene deletion mutants was compared
to that of the wild type in a growth competition assay.
Cultures grown overnight with aeration in LB, washed in
PBS and mixed in a 1:1 ratio (wild type:mutant) in human
urine (USG 1.021). Bacteria were plated on LB agar with-
and without chloramphenicol at the beginning of the ex-
periment and after 24 h in order to determine the ratio of
wild type versus mutant. The competitive index is defined
as the output ratio of CFU of mutant to wild type bacteria
divided by the input ratio of CFU of mutant to wild type
bacteria. Thus, if a mutant strain is as competitive as its
isogenic wild type parent, a value of 1 will be achieved, in-
dicating that the mutant is not attenuated.
Adhesion and infection assay
J82 were seeded into 24-well plates and grown to
confluence at which point they were infected at an
MOI of 100. The cells were washed three times in
PBS to remove the antibiotic-containing DMEM and
incubated for 1 h in prewarmed DMEM before
addition of bacteria. The plates were centrifuged at
500 xg for 5 min to synchronize infection, and incu-
bated for 1 h at 37 °C. The cells were then washed
three times with PBS to remove non-adherent bac-
teria. To measure bacterial adherence, J82 cells were
lysed by addition of 100 μl 0.25% trypsin-EDTA and
400 μL 0.1% Triton X-100 and plated onto LB agar.
Bacterial invasion was measured using a gentamicin
protection assay; after PBS wash, infected J82 cells
were incubated in DMEM with 10% FBS and 100 μg/
ml gentamicin for 2 h followed by washing, lysing
and bacterial plating as described above.
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Statistics
For RT-qPCR analysis, pairwise fixed reallocation ran-
domisation test was performed [45]. Data from growth
competition, adhesion and invasion assays were analysed
by unpaired t tests with two-tailed p-values using Graph-
Pad Prism 5 software.
Additional files
Additional file 1: Figure S1. Mutants with no growth defect. The
standard error of the mean of two independent 24-h growth experiments is
shown. The exact p-value can be seen Additional file 7: Table S3. Unpaired t
tests with two-tailed p-values were performed using GraphPad Prism
5 software. (JPG 1007 kb)
Additional file 2: Figure S2. Mutants with no cell invasion defect. The
standard error of the mean of three independent invasion assays are
shown, P > 0.05 (the exact p-value can be seen in Additional file 8: Table S5).
Unpaired t tests with two-tailed p-values were performed using GraphPad
Prism 5 software. (JPG 3856 kb)
Additional file 3: Figure S3. Muatnts with no cell adhesion defect. The
standard error of the mean of three independent invasion assays are
shown, P > 0.05 (the exact p-value can be seen in Additional file 9: Table S4).
Unpaired t tests with two-tailed p-values were performed using GraphPad
Prism 5 software. (JPG 3905 kb)
Additional file 4: Table S6. TMHMM analysis of upregulated
hypothetical genes. Gene name of hypothetical genes from Table 5, in
parenthesis are the protein BLAST results. (DOCX 13 kb)
Additional file 5: Table S7. Primers used for lambda Red
recombination. Up and Down primers are used when checking
placement of the resistance gene. KO1 and KO1 are used for PCR of the
resistance gene before the knockout reaction. (DOCX 15 kb)
Additional file 6: Table S8. Primers used for quantitative real time RT-
PCR (DOCX 15 kb)
Additional file 7: Table S3. Competitive index p-values. (DOCX 12 kb)
Additional file 8: Table S5. P-values for cell invasion assays.
(DOCX 12 kb)
Additional file 9: Table S4. P-values for cell adhesion assays.
(DOCX 12 kb)
Additional file 10: Table S1. P-values for RT-qPCR verification of genes
identified by DFI. (DOCX 12 kb)
Additional file 11: Table S2. P-values for RT-qPCR verification of genes
identified by DFI-seq. (DOCX 13 kb)
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